Related to FDA Clears Qiagen’s Rotor-Gene MDx RT-PCR IVD Platform and Influenza Assay

• FDA Green-Lights Thermo Fisher Scientific’s VRE Diagnostic
  
• FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test
  
• FDA Approves Axis-Shield and Bio-Rad’s Diagnostic for RA
  
• Qiagen and Abbott Forge Pact on Molecular Tests for HIV, HCV, and HPV
  
• AutoGenomics Granted FDA Approval for Infiniti CYP2C19 Assay
  
• FDA Sanctions Thermo Fisher Scientific’s MRSA Test for Use with Blood Samples
  
• Cepheid Launches CE-Marked Xpert Flu IVD Test in Europe
  
• Alvogen Hopes ANDA Filing for Generic Tamiflu Will Qualify for 180-Day Exclusivity
  
• ExonHit Gets EC Clearance for Alzheimer Disease In Vitro Diagnostic
  
• Roche’s Multivirus Blood-Screening Assay Achieves CE Mark
  
• FDA Grants 510(k) Clearance for Mitsubishi’s Pathfast Cardiac Troponin I Assay
  
• FDA Sanctions Abbott's Genetic FISH Panel for Leukemia Prognosis
  
• BioHelix’ IsoAmp Near-Patient HSV Diagnostic Gets FDA 510(k) Clearance
  
• FDA Clears Gen-Probe’s mRNA-Based HPV Assay for Use Alongside Pap Tests
  
• FDA Clears Abbott’s Confirmatory Chagas Disease Assay
  
• FDA Clears Hologic’s Automated Platform for Cervical Cancer Cervista HPV Assay
  
• Qiagen Signs Two Biomarker Deals and Confirms Japanese Okay for EGFR Companion Dx
  
• FDA Approves Tysabri Label Change and Test for JC Virus Infection in MS Patients
  
• FDA Clears Gen-Probe’s PCA3 Urine Assay for Predicting Need for Repeat Prostate Biopsies
  
• FDA Clears MedImmune’s FluMist Quadrivalent Flu Vaccine